MRIGlobal is in the drug-testing business.
We analyze human biological fluids for Phase-1 clinical studies to determine the chemical quantities in them. For animal models, we provide full-suite testing to establish kinetic profiles.
Our team approaches bioanalytical method validation and sample analysis with strict adherence to quality control assessment, such as routine use of system blanks and matrix evaluation precision-and-accuracy samples. Preliminary studies may be conducted as non-GLP followed by definitive GLP studies with all requisite parameters including long-term stability.
With 50 years of combined experience including method development, optimization, and validation, our team brings the passion and care necessary for sensitive projects.
We are skilled in handling drugs of abuse, investigational drugs, APIs, small molecule, peptide, and proteins. Our scientists are subject matter experts who provide exemplary service in troubleshooting, solving complex problems, and delivering meaningful data to our customers.